Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line

This study has been terminated.
(Decision from Sanofi to withdraw on a worldwide basis the Marketing Authorisation Applications for Semuloparin sodium in the adult indication)
Sponsor:
Information provided by (Responsible Party):
Sanofi
ClinicalTrials.gov Identifier:
NCT01567904
First received: March 28, 2012
Last updated: April 4, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 4, 2016